Trademark: 79398079
Word
HARNESS
Status
Pending
Status Code
630
Status Date
Thursday, June 20, 2024
Serial Number
79398079
Mark Type
4
Filing Date
Monday, February 19, 2024

Trademark Owner History

Classifications
5 Pharmaceutical preparations; medical and veterinary preparations for therapeutic purposes; biological, chemical and biochemical reagents for medical use; DNA, RNA, oligonucleotides, polynucleotides for medical use; gene editing enzymes for medical use; medical preparations containing therapeutic DNA and RNA.
1 Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, biological preparations in the nature of DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use.
42 Scientific and technological services and research and design relating thereto; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; research into DNA and RNA; research and development into the creation of DNA and RNA; research and development services in the manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; research, development, testing and analysis in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services; DNA and RNA modelling services; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; research and development services in creating libraries or collections of normal and mutated genes; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; consultancy and advisory services relating to the aforesaid services.

Trademark Events
Jun 20, 2024
Sn Assigned For Sect 66a Appl From Ib
Jun 24, 2024
New Application Office Supplied Data Entered
Jun 24, 2024
Application Filing Receipt Mailed

Trademark Alertz updated from USPTO on 2030-01-24